Evoke Pharma Inc (NASDAQ:EVOK) shares, rose in value on Wednesday, July 09, with the stock price up by 162.78% to the previous day’s close as strong demand from buyers drove the stock to $6.99.
Actively observing the price movement in the last trading, the stock closed the session at $2.66, falling within a range of $6.15 and $9.88. The value of beta (5-year monthly) was 0.025. Referring to stock’s 52-week performance, its high was $12.32, and the low was $1.94. On the whole, EVOK has fluctuated by 136.95% over the past month.
With the market capitalization of Evoke Pharma Inc currently standing at about $10.43 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 15.86M, with a low estimate of 3.8M and a high estimate of 3.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 3.8M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that EVOK’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of EVOK currently trading nearly 136.06% and 122.61% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 87.79, while the 7-day volatility ratio is showing 17.31% which for the 30-day chart, stands at 10.60%. Furthermore, Evoke Pharma Inc (EVOK)’s beta value is -0.08.
A comparison of Evoke Pharma Inc (EVOK) with its peers suggests the former has fared considerably weaker in the market. EVOK showed an intraday change of 162.78% in last session, and over the past year, it grew by 58.14%%.
Data on historical trading for Evoke Pharma Inc (NASDAQ:EVOK) indicates that the trading volumes over the past 10 days have averaged 14.01 and over the past 3 months, they’ve averaged 15.70K. According to company’s latest data on outstanding shares, there are 1.49 million shares outstanding.
Nearly 5.44% of Evoke Pharma Inc’s shares belong to company insiders and institutional investors own 16.22% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 17702.0 shares as on 2025-06-13, resulting in a short ratio of 1.01. According to the data, the short interest in Evoke Pharma Inc (EVOK) stood at 133.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 27315.0. The stock has risen by 7.87% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EVOK stock heading into the next quarter.
